ASLN - ASLAN Pharmaceuticals Limited

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 5107.31M
Enterprise value 3512.8M
Trailing P/E N/A
Forward P/E 1-3.21
PEG Ratio (5 yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)12.30
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 6N/A

Financial highlights

Currency in TWD.

Fiscal year

Fiscal year ends 31 Dec 2017
Most-recent quarter (mrq)30 Sep 2018

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-46.82%
Return on equity (ttm)-97.93%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)N/A
Diluted EPS (ttm)-0.31
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)23.43
Current ratio (mrq)5.19
Book value per share (mrq)0.26

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A

Trading information

Stock price history

Beta (3Y monthly) N/A
52-week change 3∞%
S&P500 52-week change 30.49%
52-week high 310.44
52-week low 32.51
50-day moving average 33.62
200-day moving average 35.89

Share statistics

Avg vol (3-month) 325.06k
Avg vol (10-day) 314.65k
Shares outstanding 5160.25M
Float 140.69M
% held by insiders 10.00%
% held by institutions 19.35%
Shares short (31 Jan 2019) 44.42k
Short ratio (31 Jan 2019) 40.12
Short % of float (31 Jan 2019) 4N/A
Short % of shares outstanding (31 Jan 2019) 40.01%
Shares short (prior month 31 Dec 2018) 41.51k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor (new per old) 2N/A
Last split date 3N/A